|
US2293359A
(en)
*
|
1941-01-08 |
1942-08-18 |
Quisling Sverre |
Acetyl salicylic acid preparation
|
|
FR2224175B1
(enExample)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
|
BR8007911A
(pt)
|
1979-12-06 |
1981-06-16 |
Glaxo Group Ltd |
Inalador aperfeicoado
|
|
US4375468A
(en)
|
1981-07-13 |
1983-03-01 |
Verex Laboratories, Inc. |
Constant order release aspirin composition and method of treating arthritis
|
|
US4885287A
(en)
|
1988-08-09 |
1989-12-05 |
University Of Kentucky Research Foundation |
Novel method of administering aspirin and dosage forms containing same
|
|
US5511726A
(en)
|
1988-09-23 |
1996-04-30 |
Battelle Memorial Institute |
Nebulizer device
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
EP0499142A3
(en)
|
1991-02-09 |
1993-05-05 |
Hoechst Aktiengesellschaft |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
|
|
ATE179605T1
(de)
*
|
1991-02-09 |
1999-05-15 |
B S D Bio Science Dev Snc Di O |
Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
|
|
US5256538A
(en)
*
|
1991-03-08 |
1993-10-26 |
Board Of Regents, The University Of Texas System |
Detection of early platelet activation and prediagnosis of thrombotic events
|
|
US5993805A
(en)
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
GB2265845B
(en)
|
1991-11-12 |
1996-05-01 |
Medix Ltd |
A nebuliser and nebuliser control system
|
|
US5639441A
(en)
|
1992-03-06 |
1997-06-17 |
Board Of Regents Of University Of Colorado |
Methods for fine particle formation
|
|
US5724957A
(en)
|
1993-01-29 |
1998-03-10 |
Aradigm Corporation |
Intrapulmonary delivery of narcotics
|
|
US6098620A
(en)
|
1993-01-29 |
2000-08-08 |
Aradigm Corporation |
Device for aerosolizing narcotics
|
|
US20070117862A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
GB9322014D0
(en)
*
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
PT101450B
(pt)
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
ATE287703T1
(de)
|
1995-04-14 |
2005-02-15 |
Nektar Therapeutics |
Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
|
|
WO1996032151A1
(en)
|
1995-04-14 |
1996-10-17 |
Glaxo Wellcome Inc. |
Metered dose inhaler for fluticasone propionate
|
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
KR100575070B1
(ko)
|
1997-09-29 |
2006-05-03 |
넥타르 테라퓨틱스 |
안정화된 생활성 제제 및 이의 사용 방법
|
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
|
WO2000000215A1
(en)
|
1998-06-29 |
2000-01-06 |
Inhale Therapeutic Systems, Inc. |
Particulate delivery systems and methods of use
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
IL143046A0
(en)
|
1998-11-12 |
2002-04-21 |
Pilkiewicz Frank G |
An inhalation system
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
JP3739955B2
(ja)
|
1999-01-11 |
2006-01-25 |
株式会社日立製作所 |
吸入式投薬器
|
|
US6630169B1
(en)
|
1999-03-31 |
2003-10-07 |
Nektar Therapeutics |
Particulate delivery systems and methods of use
|
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
|
EP1220698B1
(en)
|
1999-10-12 |
2004-07-21 |
SHL Medical AB |
Inhaler
|
|
EP1093814A1
(en)
|
1999-10-22 |
2001-04-25 |
Boehringer Ingelheim Pharma KG |
Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
US7089934B2
(en)
|
2000-02-28 |
2006-08-15 |
Vectura Limited |
Delivery of oral drugs
|
|
US6998137B2
(en)
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
|
EP1177805A1
(en)
|
2000-07-31 |
2002-02-06 |
Maryland Financial Inc. |
Powder inhaler
|
|
FR2812545B1
(fr)
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
|
TWI283182B
(en)
|
2000-08-07 |
2007-07-01 |
Nektar Therapeutics |
Inhalable spray dried 4-helix bundle protein powders having minimized aggregation
|
|
US20020025917A1
(en)
|
2000-08-28 |
2002-02-28 |
Edward Pappalardo |
Compartmentalized device to enable a process of liquefying and administering aspirin as a first aid to heart attack victims
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
RU2003122515A
(ru)
|
2000-12-22 |
2005-01-27 |
Эспен Аэроджелз, Инк. (Us) |
Порошок аэрогеля, включающий терапевтические средства
|
|
PL206138B1
(pl)
|
2000-12-25 |
2010-07-30 |
Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited |
Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
|
|
DE60101451T2
(de)
|
2001-03-05 |
2004-10-21 |
Pera Ivo E |
Inhaliergerät zur Verteilung von in einer Kapsel enthaltenen Medikamenten in Pulverform durch die Atemwege
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
EP1392262A1
(en)
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
JP4368198B2
(ja)
|
2001-11-20 |
2009-11-18 |
アルカーメス，インコーポレイテッド |
肺送達用の改良された粒状組成物
|
|
GB0129270D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Pharmaceutical combination
|
|
GB0129397D0
(en)
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
|
ITMI20020078A1
(it)
|
2002-01-16 |
2003-07-16 |
Fabrizio Niccolai |
Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
SE524990C2
(sv)
|
2002-04-12 |
2004-11-09 |
Microdrug Ag |
Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
US20040092470A1
(en)
|
2002-06-18 |
2004-05-13 |
Leonard Sherry A. |
Dry powder oligonucleotide formualtion, preparation and its uses
|
|
JP2006503865A
(ja)
|
2002-09-30 |
2006-02-02 |
アキュスフィア， インコーポレイテッド |
吸入のための徐放性の多孔性微粒子
|
|
GB0226105D0
(en)
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
|
US7516741B2
(en)
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
|
US7284553B2
(en)
|
2002-12-12 |
2007-10-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
US20040206350A1
(en)
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
|
US7669596B2
(en)
|
2002-12-31 |
2010-03-02 |
Novartis Pharma Ag |
Aerosolization apparatus with rotating capsule
|
|
US7878193B2
(en)
|
2003-01-14 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Capsule for taking an active substance which can be inhaled
|
|
ES2383367T5
(es)
|
2003-04-09 |
2021-03-31 |
Novartis Ag |
Aparato de pulverización en forma de aerosol con protección de entrada de aire
|
|
HUE026950T2
(en)
|
2003-04-09 |
2016-08-29 |
Novartis Ag |
Nozzle with guide wire for puncturing the capsule
|
|
CA2521394A1
(en)
|
2003-04-09 |
2004-10-28 |
Wyeth |
Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
|
|
GB0312419D0
(en)
|
2003-05-30 |
2003-07-02 |
Boots Healthcare Int Ltd |
Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
|
|
ES2872350T3
(es)
|
2003-06-13 |
2021-11-02 |
Civitas Therapeutics Inc |
Polvos farmacéuticos de dosis baja para inhalación
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
JP2007531701A
(ja)
|
2003-07-18 |
2007-11-08 |
バクスター・インターナショナル・インコーポレイテッド |
制御された相分離により調製される小球状粒子の作製方法、使用および組成物
|
|
JP2007502815A
(ja)
|
2003-08-20 |
2007-02-15 |
イーライ リリー アンド カンパニー |
Ｐｐａｒ調節因子
|
|
CA2536293A1
(en)
|
2003-08-22 |
2005-03-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating copd and pulmonary hypertension
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
GB2407040B
(en)
|
2003-10-15 |
2007-09-19 |
Sheikh Arshad Saeed |
Anti-platelet aggregation compositions
|
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
|
WO2005041886A2
(en)
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
WO2005079234A2
(en)
|
2004-02-05 |
2005-09-01 |
Etienne-Emile Baulieu |
Treatment of pulmonary artery hypertension with dhea, dheas, dhea analogs or dhea derivatives
|
|
JP2007523197A
(ja)
|
2004-02-23 |
2007-08-16 |
プロレキシーズ ファーマシューティカルズ インコーポレイテッド |
ｐＨＳＰ２０様活性を有する非ペプチジル剤、およびその使用
|
|
CN101098678A
(zh)
|
2004-04-23 |
2008-01-02 |
锡德克斯公司 |
含有磺基烷基醚环糊精的dpi制剂
|
|
BRPI0510666A
(pt)
|
2004-05-04 |
2007-12-04 |
Pfizer |
compostos de amida de arila ou heteroarila de metila substituìda, composições farmacêuticas compreendendo os mesmos, uso e combinação
|
|
US7189750B2
(en)
|
2004-05-05 |
2007-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
|
|
US7968575B2
(en)
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
CA2567056A1
(en)
|
2004-05-10 |
2005-12-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
US7556035B2
(en)
|
2004-05-28 |
2009-07-07 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
|
EP1773370A1
(en)
|
2004-07-07 |
2007-04-18 |
Medicure International Inc. |
Combination therapies employing platelet aggregation drugs
|
|
WO2006017354A1
(en)
|
2004-07-13 |
2006-02-16 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
EP1819329A2
(en)
|
2004-08-04 |
2007-08-22 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
|
US7682614B2
(en)
|
2004-11-02 |
2010-03-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for inhibition of NKT cells
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
ITMI20050417A1
(it)
*
|
2005-03-15 |
2006-09-16 |
Medestea Res & Production S R L |
Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
|
|
JP2008539890A
(ja)
|
2005-05-05 |
2008-11-20 |
プルマトリックス インコーポレイテッド |
超音波式エアロゾルゼネレーター
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
CA2616778A1
(en)
|
2005-07-27 |
2007-02-01 |
Nastech Pharmaceutical Company Inc. |
Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
|
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
EP1968550A2
(en)
|
2005-12-16 |
2008-09-17 |
University Of Kansas |
Nanoclusters for delivery of therapeutics
|
|
WO2007072503A2
(en)
|
2005-12-21 |
2007-06-28 |
Panacea Biotec Ltd. |
Combinations for managing inflammation and associated disorders
|
|
US7201929B1
(en)
|
2005-12-30 |
2007-04-10 |
Alan James Group, Llc. |
Aspirin formulation for cardiovascular health
|
|
KR102109867B1
(ko)
|
2006-01-24 |
2020-05-13 |
안선 바이오파르마, 아이엔씨. |
고분자 미소 구체들의 조제를 위한 기술
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
US7806117B2
(en)
|
2006-06-07 |
2010-10-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Peroral powder delivery device
|
|
EP2035068A1
(en)
|
2006-06-27 |
2009-03-18 |
Brin Tech International Limited |
Inhaler
|
|
HUE048024T2
(hu)
|
2006-08-10 |
2020-05-28 |
Roy C Levitt |
Anakinra bronchiolitis obliterans szindróma kezelésében való alkalmazásra
|
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
|
US20080063722A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Advanced Inhalation Research, Inc. |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
GB0621957D0
(en)
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
|
NL1033047C2
(nl)
|
2006-12-13 |
2008-06-16 |
Pharmachemie Bv |
Capsule, gevuld met een medicijn, in het bijzonder een inhaleerbaar medicijn.
|
|
GB0625303D0
(en)
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
|
GB0700839D0
(en)
|
2007-01-17 |
2007-02-21 |
Braithwaite Philip |
Device
|
|
EP1964564A1
(en)
|
2007-04-19 |
2008-09-03 |
LAB International SRL |
Breakthrough Pain Management
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
AU2008266948B2
(en)
|
2007-06-13 |
2012-08-23 |
Kirin-Amgen, Inc. |
IL-17 heteromeric receptor complex
|
|
JP2010533181A
(ja)
|
2007-07-13 |
2010-10-21 |
アボツト・バイオテクノロジー・リミテツド |
ＴＮＦα阻害剤の肺投与のための方法及び組成物
|
|
CA2692892A1
(en)
|
2007-07-24 |
2009-01-29 |
Michael Malakhov |
Technology for the preparation of microparticles
|
|
US9358242B2
(en)
|
2007-08-30 |
2016-06-07 |
Prelief Inc. |
Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
|
|
BRPI0821111A2
(pt)
|
2007-12-05 |
2015-06-16 |
Novartis Ag |
Recptáculo para uma formulação farmacêutica aerossoliza´vel
|
|
EP2227085A4
(en)
|
2007-12-06 |
2013-10-09 |
Berg Pharma Llc |
INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
|
|
CA2710349A1
(en)
|
2007-12-27 |
2009-07-09 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
|
|
DE102008004386A1
(de)
*
|
2008-01-14 |
2009-07-23 |
Activaero Gmbh |
Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
|
|
RU2534527C2
(ru)
|
2008-01-15 |
2014-11-27 |
Юниверсите Де Страсбур |
Синтез лактонов резорциловой кислоты, используемых в качестве терапевтических агентов
|
|
MY184345A
(en)
|
2008-02-21 |
2021-04-01 |
Amgen Inc |
Il-17ra-il-17rb antagonists and uses thereof
|
|
GB0803369D0
(en)
|
2008-02-25 |
2008-04-02 |
Helperby Therapeutics Ltd |
Biological materials and uses thereof
|
|
WO2009123948A2
(en)
|
2008-04-04 |
2009-10-08 |
Irm Llc |
Compounds and compositions as itpkb inhibitors
|
|
US20090257957A1
(en)
|
2008-04-15 |
2009-10-15 |
John Burnier |
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
|
|
BRPI0912668A2
(pt)
|
2008-05-13 |
2016-01-26 |
Irm Llc |
composto e composições como inibidores de quinase
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
TWI677355B
(zh)
|
2008-06-13 |
2019-11-21 |
美商曼凱公司 |
用於藥物傳輸之乾粉吸入器及系統
|
|
KR20110045004A
(ko)
|
2008-07-15 |
2011-05-03 |
쉐링 코포레이션 |
충혈제거제 및 코르티코스테로이드를 포함하는 비강내 조성물
|
|
WO2010007446A1
(en)
|
2008-07-18 |
2010-01-21 |
Prosonix Limited |
Process for improving crystallinity of fluticasone particles
|
|
WO2010011329A2
(en)
|
2008-07-23 |
2010-01-28 |
Map Pharmaceuticals, Inc. |
The delivery of powdered drug via inhalation
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
GB2463565A
(en)
|
2008-09-12 |
2010-03-24 |
Critical Pharmaceuticals Ltd |
Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
|
|
MX357919B
(es)
|
2009-03-13 |
2018-07-25 |
Nucitec Sa De Cv |
Composición farmacéutica para el tratamiento de la hipercolesterolemia.
|
|
RU2577698C2
(ru)
*
|
2009-03-26 |
2016-03-20 |
Пулмэтрикс, Инк. |
Сухие порошкообразные составы и способы лечения легочных заболеваний
|
|
US20120046251A1
(en)
|
2009-04-06 |
2012-02-23 |
The Regents Of The University Of California |
Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
|
|
ES2552805T3
(es)
|
2009-04-20 |
2015-12-02 |
Auspex Pharmaceuticals, Llc |
Inhibidores piperidínicos de la cinasa Janus 3
|
|
GB0908129D0
(en)
|
2009-05-12 |
2009-06-24 |
Innovata Ltd |
Composition
|
|
JP2012526726A
(ja)
|
2009-05-15 |
2012-11-01 |
株式会社新日本科学 |
薬物動態が改善された鼻腔内用薬学的組成物
|
|
US9125999B2
(en)
|
2009-05-18 |
2015-09-08 |
Adamis Pharmaceuticals Corporation |
Dry powder inhaler dose counters
|
|
ES2769082T3
(es)
|
2009-05-18 |
2020-06-24 |
Adamis Pharmaceuticals Corp |
Inhaladores de polvo seco
|
|
WO2010139985A1
(en)
|
2009-06-01 |
2010-12-09 |
Biocopea Limited |
The use of amlexanox in the therapy of neutrophil-driven diseases
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
GB0914231D0
(en)
*
|
2009-08-14 |
2009-09-30 |
Breath Ltd |
Dry powder inhaler formulations
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
GB0918431D0
(en)
|
2009-10-21 |
2009-12-09 |
Prosonix Ltd |
Process for improving crystallinity
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
SG184473A1
(en)
|
2010-04-07 |
2012-11-29 |
Abbvie Inc |
Tnf-alpha binding proteins
|
|
CA2809666C
(en)
|
2010-08-30 |
2020-09-22 |
Michael M. Lipp |
Dry powder formulations and methods for treating pulmonary diseases
|
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
|
WO2012061902A1
(en)
|
2010-11-12 |
2012-05-18 |
Monash University |
Micronised spray-dried particles comprising polymyxin
|
|
WO2012078804A1
(en)
*
|
2010-12-07 |
2012-06-14 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
CN102058886A
(zh)
|
2010-12-20 |
2011-05-18 |
云南白药集团无锡药业有限公司 |
医用粉雾剂及其应用
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
GB201102237D0
(en)
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
JP6031510B2
(ja)
|
2011-04-12 |
2016-11-24 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
|
|
US8580853B2
(en)
*
|
2011-06-13 |
2013-11-12 |
Howard PHYKITT |
Analgesic composition and method of making the same
|
|
KR102058256B1
(ko)
|
2011-06-17 |
2020-01-22 |
버그 엘엘씨 |
흡입성 약제학적 조성물들
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
GB2499559B8
(en)
|
2011-09-06 |
2014-04-02 |
Verona Pharma Plc |
Treating cough and tussive attacks
|
|
CA2858997C
(en)
|
2011-12-16 |
2020-03-31 |
Indosys Limited |
Medicament unit dose cartridge and delivery device
|
|
US20130196906A1
(en)
|
2012-01-31 |
2013-08-01 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
US10022303B2
(en)
|
2012-02-28 |
2018-07-17 |
Iceutica Pty Ltd. |
Inhalable pharmaceutical compositions
|
|
CA2865972C
(en)
|
2012-02-29 |
2022-01-04 |
Pulmatrix, Inc. |
Inhalable dry powders
|
|
US9663511B2
(en)
|
2012-03-26 |
2017-05-30 |
Arroyo BioSciences, LLC |
Sphingosine 1-phosphate receptor antagonists
|
|
GB201205632D0
(en)
|
2012-03-30 |
2012-05-16 |
Vectura Ltd |
Method and apparatus
|
|
US20130316001A1
(en)
|
2012-05-03 |
2013-11-28 |
Kala Pharmaceuticals, Inc. |
Particles, compositions and methods for ophthalmic and/or other applications
|
|
WO2013169473A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Virginia Commonwealth University |
Dry powder inhaler (dpi) designs for producing aerosols with high fine particle fractions
|
|
WO2013176622A1
(en)
|
2012-05-21 |
2013-11-28 |
Agency For Science, Technology And Research (A*Star) |
A dry powder formulation
|
|
US20140005379A1
(en)
|
2012-06-20 |
2014-01-02 |
Frank GU |
Nanoparticle delivery system and components thereof
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
US20150224129A1
(en)
|
2012-10-03 |
2015-08-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
|
|
EP2916836A4
(en)
|
2012-11-07 |
2016-08-03 |
Merck Sharp & Dohme |
AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
CN110403922A
(zh)
|
2013-01-28 |
2019-11-05 |
理森制药股份公司 |
通过吸入罗氟司特n-氧化物治疗自身免疫、呼吸和/或炎性病症的方法
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
GB201305813D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
Compositions and methods
|
|
JP2016518388A
(ja)
|
2013-04-30 |
2016-06-23 |
オティトピック インク． |
乾燥粉末配合および使用方法
|
|
MX381503B
(es)
|
2013-05-23 |
2025-03-12 |
Aztherapies Inc |
Métodos para la liberación de cromolina.
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
|
|
JP6483714B2
(ja)
|
2013-10-11 |
2019-03-13 |
ローレンス エス． ジスマン， |
噴霧乾燥製剤
|
|
CA2977083A1
(en)
|
2014-02-20 |
2015-08-27 |
Kambiz Yadidi |
Dry powder formulations for inhalation
|
|
RU2693430C2
(ru)
|
2014-02-20 |
2019-07-02 |
Аллерган, Инк. |
Антитела к компоненту комплемента с5
|
|
CA2939586A1
(en)
|
2014-02-27 |
2015-09-03 |
Allergan, Inc. |
Complement factor bb antibodies
|
|
CN106715443A
(zh)
|
2014-03-26 |
2017-05-24 |
坎格特生物技术制药有限责任公司 |
Fl118母核化学结构平台产生用于治疗人类疾病的fl118衍生物的用途
|
|
WO2015153838A1
(en)
|
2014-04-02 |
2015-10-08 |
Rogne Bioscience Inc. |
Methods and compositions for treating inflammatory disorders
|
|
US20170027963A1
(en)
|
2014-04-10 |
2017-02-02 |
Patrick Crowley |
Delivery of non-steroidal agents to the brain via the nasal tract to treat neurological disorders
|
|
WO2016176552A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Otitopic Inc. |
Dry power formulations for inhalation
|
|
EP3463378A4
(en)
*
|
2016-06-03 |
2020-01-08 |
Otitopic Inc. |
DRY POWDER FORMULAS FOR INHALATION
|
|
KR102507987B1
(ko)
*
|
2017-09-22 |
2023-03-21 |
벡추라 인코포레이티드 |
스테아르산마그네슘을 갖는 건조 분말 조성물
|
|
US10786456B2
(en)
*
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|